欧洲胰岛素输液泵市场 - 增长、趋势、COVID-19 影响和预测 (2023 - 2028)

市场按组件（泵装置、输液器和储液器）和区域划分。

Home right-chevron-icon Industry Reports right-chevron-icon Healthcare right-chevron-icon Diabetes Drugs & Devices right-chevron-icon Europe Insulin Infusion Pumps Market right-chevron-icon 欧洲胰岛素输液泵市场

市场快照

Picture1
Study Period: 2018 - 2026
CAGR: 0 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and it's growth?

市场概况

  • 胰岛素泵（也称为连续皮下胰岛素治疗）是一种用于在糖尿病治疗中给予胰岛素的医疗器械。胰岛素泵可以定期输送连续输注量的胰岛素。
  • 预计相对于每天多次注射，可以节省长期成本。传统的泵包括泵（包括控制器、处理模块和电池）、一次性胰岛素储液罐（在泵内）和一次性输液器，包括用于皮下插入（皮下）的套管和管道系统将胰岛素储液罐连接到套管。
  • 设备配置可能因设计而异。然而，输液泵的应用在世界范围内显着增加。

报告范围

市场按组件（泵装置、输液器和储液器）和地区划分。

By Product (Value and Volume, 2012-2024)
Insulin Pump
Infusion Set
Reservoir
By Geography
Europe
France (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Germany (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Italy (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Spain (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Russia (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Rest of Europe (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir

Report scope can be customized per your requirements. Click here.

主要市场趋势

糖尿病患病率的增加和胰岛素输送系统的技术进步

  • 欧洲地区所有年龄段的糖尿病患病率都在增加，主要是由于肥胖、不健康的饮食和缺乏身体活动。
  • 自身免疫性 1 型糖尿病的患病率在欧洲也在增长，据消息来源称，欧洲患有 1 型糖尿病患者的儿童人数最多。
  • 对儿童 1 型糖尿病患者总数贡献最大的欧洲国家是英国、俄罗斯联邦和德国。这种需求激增，对胰岛素市场有相当大的需求。
  • 糖尿病患者都知道，将血糖水平保持在安全范围内极为重要，良好的血糖控制不仅能让人感觉良好，还有助于预防糖尿病的长期并发症，如失明、肾衰竭和心脏病。
  • 随着技术的进步，已经为需要更严格控制血糖和糖化血红蛋白水平 (HbA1C) 的患者发现了一种更好的胰岛素给药方式，从而减少了与糖尿病相关的长期并发症的机会。一种这样的进步是通过胰岛素泵输送胰岛素。
Picture3

德国在欧洲胰岛素泵市场占有率最高

  • 2018年德国在欧洲胰岛素输液泵市场占有34%的市场份额，由于有利的报销政策，预计在预测期内的复合年增长率为4%。 
Picture4

竞争格局

  • 由于竞争加剧，Animas 不得不退出胰岛素泵市场。
  • 美敦力是市场领导者，预计在预测期内将保持其地位。

主要玩家

  1. Medtronic

  2. Roche

  3. Ypsomed

*Disclaimer: Major Players sorted in no particular order

Picture5

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product (Value and Volume, 2012-2024)

      1. 5.1.1 Insulin Pump

      2. 5.1.2 Infusion Set

      3. 5.1.3 Reservoir

    2. 5.2 By Geography

      1. 5.2.1 Europe

        1. 5.2.1.1 France (Value and Volume, 2012-2024)

          1. 5.2.1.1.1 By Insulin Pump Device

          2. 5.2.1.1.2 By Infusion Set

          3. 5.2.1.1.3 By Reservoir

        2. 5.2.1.2 Germany (Value and Volume, 2012-2024)

          1. 5.2.1.2.1 By Insulin Pump Device

          2. 5.2.1.2.2 By Infusion Set

          3. 5.2.1.2.3 By Reservoir

        3. 5.2.1.3 Italy (Value and Volume, 2012-2024)

          1. 5.2.1.3.1 By Insulin Pump Device

          2. 5.2.1.3.2 By Infusion Set

          3. 5.2.1.3.3 By Reservoir

        4. 5.2.1.4 Spain (Value and Volume, 2012-2024)

          1. 5.2.1.4.1 By Insulin Pump Device

          2. 5.2.1.4.2 By Infusion Set

          3. 5.2.1.4.3 By Reservoir

        5. 5.2.1.5 Russia (Value and Volume, 2012-2024)

          1. 5.2.1.5.1 By Insulin Pump Device

          2. 5.2.1.5.2 By Infusion Set

          3. 5.2.1.5.3 By Reservoir

        6. 5.2.1.6 Rest of Europe (Value and Volume, 2012-2024)

          1. 5.2.1.6.1 By Insulin Pump Device

          2. 5.2.1.6.2 By Infusion Set

          3. 5.2.1.6.3 By Reservoir

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2024)

    2. 6.2 Type-2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Medtronic

      2. 7.1.2 Insulet

      3. 7.1.3 Roche

      4. 7.1.4 Animas

      5. 7.1.5 Tandem

      6. 7.1.6 Ypsomed

      7. 7.1.7 Cellnovo

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Animas

      3. 7.2.3 Medtronic

      4. 7.2.4 Others

  8. 8. MARKET OPPORTUNITES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

从 2018 年到 2028 年研究了欧洲胰岛素输液泵市场。

未来 5 年，欧洲胰岛素输液泵市场的复合年增长率将超过 4%。

2018 年欧洲胰岛素输液泵市场价值 5.13 亿美元。

2028 年欧洲胰岛素输液泵市场价值 6.35 亿美元。

美敦力、罗氏、Ypsomed、Insulet 是欧洲胰岛素输液泵市场的主要公司。

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!